Bcl2L1 Protein — Bcl Xl is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Name | BCL-XL (B-Cell Lymphoma-Extra Large) |
|---|---|
| Gene | [BCL2L1](/genes/bcl2l1) |
| UniProt ID | [Q07817](https://www.uniprot.org/uniprot/Q07817) |
| Protein Size | 233 amino acids (~30 kDa); alternative splicing generates BCL-XS (178 aa) |
| Subcellular Localization | Mitochondrial outer membrane; endoplasmic reticulum; nucleus |
| Protein Family | BCL-2 family (anti-apoptotic) |
| PDB Structures | [1LXL](https://www.ebi.ac.uk/pdbe/search/pdb/1LXL), [1R2D](https://www.ebi.ac.uk/pdbe/search/pdb/1R2D), [5AGW](https://www.ebi.ac.uk/pdbe/search/pdb/5AGW) |
BCL-XL (BCL2L1) is a critical anti-apoptotic protein of the BCL-2 family that inhibits mitochondrial apoptosis by preventing mitochondrial outer membrane permeabilization (MOMP). It is a key regulator of neuronal survival and is implicated in various neurodegenerative diseases.
BCL-XL has the characteristic BCL-2 family fold:
The protein forms a hydrophobic groove that binds the BH3 domains of pro-apoptotic proteins.
Alternative Splicing: BCL2L1 produces two major isoforms:
BCL-XL performs essential anti-apoptotic functions:
Inhibition of MOMP: Prevents mitochondrial outer membrane permeabilization by sequestering BH3-only proteins and inhibiting BAX/BAK activation[1].
Mitochondrial Stability: Maintains mitochondrial integrity and prevents release of cytochrome c and other pro-apoptotic factors.
Regulation of Autophagy: Interacts with BECN1 to regulate autophagy; BCL-XL binds and inhibits BECN1.
Neuronal Development: Critical for development and survival of specific neuronal populations.
Synaptic Protection: Protects synapses from apoptotic-induced elimination during development.
BCL-XL is a major therapeutic target:
Important: BCL-XL inhibition can cause thrombocytopenia because platelets depend on BCL-XL for survival.
BCL-XL interacts with:
The study of Bcl2L1 Protein — Bcl Xl has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.